Page last updated: 2024-11-13

ethyl 1-(4-(2,3,3-trichloroacrylamido)phenyl)-5-(trifluoromethyl)-1h-pyrazole-4-carboxylate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

ethyl 1-(4-(2,3,3-trichloroacrylamido)phenyl)-5-(trifluoromethyl)-1H-pyrazole-4-carboxylate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID56964346
CHEMBL ID4177187
SCHEMBL ID12274132
MeSH IDM0543093

Synonyms (23)

Synonym
pyr3
1160514-60-2
ethyl 1-[4-(trichloroprop-2-enamido)phenyl]-5-(trifluoromethyl)-1h-pyrazole-4-carboxylate
gtpl4293
SCHEMBL12274132
1-[4-[(2,3,3-trichloro-1-oxo-2-propen-1-yl)amino]phenyl]-5-(trifluoromethyl)-1h-pyrazole-4-carboxylic acid
AKOS024457787
J-003374
DTXSID60719181
ethyl 1-{4-[(2,3,3-trichloroacryloyl)amino]phenyl}-5-(trifluoromethyl)-1h-pyrazole-4-carboxylate
pyr3, >=98% (hplc)
NCGC00370970-01
bdbm50450629
rzhgonnsasqoay-uhfffaoysa-n
ethyl 1-(4-(2,3,3-trichloroacrylamido)phenyl)-5-(trifluoromethyl)-1h-pyrazole-4-carboxylate
1-[4-(2,3,3-trichloro-acryloylamino)-phenyl]-5-trifluoromethyl-1h-pyrazole-4-carboxylic acid ethyl ester
Q27088485
CS-0028846
HY-108465
1h-pyrazole-4-carboxylic acid, 1-[4-[(2,3,3-trichloro-1-oxo-2-propen-1-yl)amino]phenyl]-5-(trifluoromethyl)-, ethyl ester
ethyl 1-[4-(2,3,3-trichloroprop-2-enoylamino)phenyl]-5-(trifluoromethyl)pyrazole-4-carboxylate
MS-28331
CHEMBL4177187 ,

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Protein Targets (15)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
cytochrome P450 family 3 subfamily A polypeptide 4Homo sapiens (human)Potency2.39190.01237.983543.2770AID1645841
GVesicular stomatitis virusPotency6.74120.01238.964839.8107AID1645842
cytochrome P450 2D6Homo sapiens (human)Potency15.09160.00108.379861.1304AID1645840
Interferon betaHomo sapiens (human)Potency6.74120.00339.158239.8107AID1645842
HLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)Potency6.74120.01238.964839.8107AID1645842
Inositol hexakisphosphate kinase 1Homo sapiens (human)Potency6.74120.01238.964839.8107AID1645842
cytochrome P450 2C9, partialHomo sapiens (human)Potency6.74120.01238.964839.8107AID1645842
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Short transient receptor potential channel 1Homo sapiens (human)IC50 (µMol)0.50000.50000.50000.5000AID1363555
Stromal interaction molecule 1Rattus norvegicus (Norway rat)IC50 (µMol)0.54000.54000.56500.5900AID1578744
Short transient receptor potential channel 3Homo sapiens (human)IC50 (µMol)0.54800.47002.29299.1000AID1363555; AID1578741; AID1578743; AID1709630; AID1709631
Stromal interaction molecule 1Homo sapiens (human)IC50 (µMol)1.70000.50002.78334.3000AID1363555; AID1363557
Calcium release-activated calcium channel protein 1Rattus norvegicus (Norway rat)IC50 (µMol)0.54000.54000.56500.5900AID1578744
Calcium release-activated calcium channel protein 1Homo sapiens (human)IC50 (µMol)1.70000.50004.25009.8000AID1363555; AID1363557
Stromal interaction molecule 2Homo sapiens (human)IC50 (µMol)2.90002.90002.90002.9000AID1363557
Short transient receptor potential channel 3 Mus musculus (house mouse)IC50 (µMol)0.70000.70000.70000.7000AID1709647
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (73)

Processvia Protein(s)Taxonomy
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell activation involved in immune responseInterferon betaHomo sapiens (human)
cell surface receptor signaling pathwayInterferon betaHomo sapiens (human)
cell surface receptor signaling pathway via JAK-STATInterferon betaHomo sapiens (human)
response to virusInterferon betaHomo sapiens (human)
positive regulation of autophagyInterferon betaHomo sapiens (human)
cytokine-mediated signaling pathwayInterferon betaHomo sapiens (human)
natural killer cell activationInterferon betaHomo sapiens (human)
positive regulation of peptidyl-serine phosphorylation of STAT proteinInterferon betaHomo sapiens (human)
cellular response to interferon-betaInterferon betaHomo sapiens (human)
B cell proliferationInterferon betaHomo sapiens (human)
negative regulation of viral genome replicationInterferon betaHomo sapiens (human)
innate immune responseInterferon betaHomo sapiens (human)
positive regulation of innate immune responseInterferon betaHomo sapiens (human)
regulation of MHC class I biosynthetic processInterferon betaHomo sapiens (human)
negative regulation of T cell differentiationInterferon betaHomo sapiens (human)
positive regulation of transcription by RNA polymerase IIInterferon betaHomo sapiens (human)
defense response to virusInterferon betaHomo sapiens (human)
type I interferon-mediated signaling pathwayInterferon betaHomo sapiens (human)
neuron cellular homeostasisInterferon betaHomo sapiens (human)
cellular response to exogenous dsRNAInterferon betaHomo sapiens (human)
cellular response to virusInterferon betaHomo sapiens (human)
negative regulation of Lewy body formationInterferon betaHomo sapiens (human)
negative regulation of T-helper 2 cell cytokine productionInterferon betaHomo sapiens (human)
positive regulation of apoptotic signaling pathwayInterferon betaHomo sapiens (human)
response to exogenous dsRNAInterferon betaHomo sapiens (human)
B cell differentiationInterferon betaHomo sapiens (human)
natural killer cell activation involved in immune responseInterferon betaHomo sapiens (human)
adaptive immune responseInterferon betaHomo sapiens (human)
T cell activation involved in immune responseInterferon betaHomo sapiens (human)
humoral immune responseInterferon betaHomo sapiens (human)
positive regulation of T cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
adaptive immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independentHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of T cell anergyHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
defense responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
detection of bacteriumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-12 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of interleukin-6 productionHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protection from natural killer cell mediated cytotoxicityHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
innate immune responseHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
regulation of dendritic cell differentiationHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
antigen processing and presentation of endogenous peptide antigen via MHC class IbHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
calcium ion transportShort transient receptor potential channel 1Homo sapiens (human)
melanin biosynthetic processShort transient receptor potential channel 1Homo sapiens (human)
positive regulation of release of sequestered calcium ion into cytosolShort transient receptor potential channel 1Homo sapiens (human)
regulation of cytosolic calcium ion concentrationShort transient receptor potential channel 1Homo sapiens (human)
response to calcium ionShort transient receptor potential channel 1Homo sapiens (human)
calcium ion transmembrane transportShort transient receptor potential channel 1Homo sapiens (human)
regulation of cardiac conductionShort transient receptor potential channel 1Homo sapiens (human)
calcium ion transportShort transient receptor potential channel 3Homo sapiens (human)
phototransductionShort transient receptor potential channel 3Homo sapiens (human)
positive regulation of calcium ion transport into cytosolShort transient receptor potential channel 3Homo sapiens (human)
response to ATPShort transient receptor potential channel 3Homo sapiens (human)
response to calcium ionShort transient receptor potential channel 3Homo sapiens (human)
calcium ion transmembrane transportShort transient receptor potential channel 3Homo sapiens (human)
positive regulation of cardiac muscle hypertrophy in response to stressShort transient receptor potential channel 3Homo sapiens (human)
single fertilizationShort transient receptor potential channel 3Homo sapiens (human)
regulation of cytosolic calcium ion concentrationShort transient receptor potential channel 3Homo sapiens (human)
store-operated calcium entryStromal interaction molecule 1Homo sapiens (human)
detection of calcium ionStromal interaction molecule 1Homo sapiens (human)
activation of store-operated calcium channel activityStromal interaction molecule 1Homo sapiens (human)
positive regulation of adenylate cyclase activityStromal interaction molecule 1Homo sapiens (human)
positive regulation of angiogenesisStromal interaction molecule 1Homo sapiens (human)
regulation of calcium ion transportStromal interaction molecule 1Homo sapiens (human)
enamel mineralizationStromal interaction molecule 1Homo sapiens (human)
regulation of store-operated calcium entryStromal interaction molecule 1Homo sapiens (human)
intracellular calcium ion homeostasisStromal interaction molecule 1Homo sapiens (human)
inositol phosphate metabolic processInositol hexakisphosphate kinase 1Homo sapiens (human)
phosphatidylinositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
negative regulation of cold-induced thermogenesisInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol phosphate biosynthetic processInositol hexakisphosphate kinase 1Homo sapiens (human)
store-operated calcium entryCalcium release-activated calcium channel protein 1Homo sapiens (human)
adaptive immune responseCalcium release-activated calcium channel protein 1Homo sapiens (human)
phospholipase C-activating G protein-coupled receptor signaling pathwayCalcium release-activated calcium channel protein 1Homo sapiens (human)
positive regulation of insulin secretionCalcium release-activated calcium channel protein 1Homo sapiens (human)
positive regulation of adenylate cyclase activityCalcium release-activated calcium channel protein 1Homo sapiens (human)
regulation of calcium ion transportCalcium release-activated calcium channel protein 1Homo sapiens (human)
positive regulation of calcium ion transportCalcium release-activated calcium channel protein 1Homo sapiens (human)
mammary gland epithelium developmentCalcium release-activated calcium channel protein 1Homo sapiens (human)
calcium ion importCalcium release-activated calcium channel protein 1Homo sapiens (human)
calcium ion transmembrane transportCalcium release-activated calcium channel protein 1Homo sapiens (human)
ion channel modulating, G protein-coupled receptor signaling pathwayCalcium release-activated calcium channel protein 1Homo sapiens (human)
ligand-gated ion channel signaling pathwayCalcium release-activated calcium channel protein 1Homo sapiens (human)
intracellular calcium ion homeostasisStromal interaction molecule 2Homo sapiens (human)
activation of store-operated calcium channel activityStromal interaction molecule 2Homo sapiens (human)
positive regulation of calcium ion transportStromal interaction molecule 2Homo sapiens (human)
calcium ion transmembrane transportStromal interaction molecule 2Homo sapiens (human)
store-operated calcium entryStromal interaction molecule 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (31)

Processvia Protein(s)Taxonomy
cytokine activityInterferon betaHomo sapiens (human)
cytokine receptor bindingInterferon betaHomo sapiens (human)
type I interferon receptor bindingInterferon betaHomo sapiens (human)
protein bindingInterferon betaHomo sapiens (human)
chloramphenicol O-acetyltransferase activityInterferon betaHomo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
peptide antigen bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
TAP bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
protein-folding chaperone bindingHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
signaling receptor bindingShort transient receptor potential channel 1Homo sapiens (human)
monoatomic cation channel activityShort transient receptor potential channel 1Homo sapiens (human)
calcium channel activityShort transient receptor potential channel 1Homo sapiens (human)
protein bindingShort transient receptor potential channel 1Homo sapiens (human)
ATPase bindingShort transient receptor potential channel 1Homo sapiens (human)
inositol 1,4,5 trisphosphate bindingShort transient receptor potential channel 1Homo sapiens (human)
store-operated calcium channel activityShort transient receptor potential channel 1Homo sapiens (human)
calcium-activated cation channel activityShort transient receptor potential channel 3Homo sapiens (human)
calcium channel activityShort transient receptor potential channel 3Homo sapiens (human)
protein bindingShort transient receptor potential channel 3Homo sapiens (human)
metal ion bindingShort transient receptor potential channel 3Homo sapiens (human)
inositol 1,4,5 trisphosphate bindingShort transient receptor potential channel 3Homo sapiens (human)
store-operated calcium channel activityShort transient receptor potential channel 3Homo sapiens (human)
protease bindingStromal interaction molecule 1Homo sapiens (human)
calcium channel regulator activityStromal interaction molecule 1Homo sapiens (human)
calcium ion bindingStromal interaction molecule 1Homo sapiens (human)
protein bindingStromal interaction molecule 1Homo sapiens (human)
identical protein bindingStromal interaction molecule 1Homo sapiens (human)
microtubule plus-end bindingStromal interaction molecule 1Homo sapiens (human)
inositol-1,3,4,5,6-pentakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol heptakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
protein bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
ATP bindingInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 1-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol hexakisphosphate 3-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol 5-diphosphate pentakisphosphate 5-kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
inositol diphosphate tetrakisphosphate kinase activityInositol hexakisphosphate kinase 1Homo sapiens (human)
calcium channel activityCalcium release-activated calcium channel protein 1Homo sapiens (human)
protein bindingCalcium release-activated calcium channel protein 1Homo sapiens (human)
calmodulin bindingCalcium release-activated calcium channel protein 1Homo sapiens (human)
store-operated calcium channel activityCalcium release-activated calcium channel protein 1Homo sapiens (human)
identical protein bindingCalcium release-activated calcium channel protein 1Homo sapiens (human)
calcium channel regulator activityStromal interaction molecule 2Homo sapiens (human)
calcium ion bindingStromal interaction molecule 2Homo sapiens (human)
protein bindingStromal interaction molecule 2Homo sapiens (human)
store-operated calcium channel activityStromal interaction molecule 2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (32)

Processvia Protein(s)Taxonomy
extracellular spaceInterferon betaHomo sapiens (human)
extracellular regionInterferon betaHomo sapiens (human)
Golgi membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
endoplasmic reticulumHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
Golgi apparatusHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
cell surfaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
ER to Golgi transport vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
secretory granule membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
phagocytic vesicle membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
early endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
recycling endosome membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular exosomeHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
lumenal side of endoplasmic reticulum membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
MHC class I protein complexHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
extracellular spaceHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
external side of plasma membraneHLA class I histocompatibility antigen, B alpha chain Homo sapiens (human)
plasma membraneShort transient receptor potential channel 1Homo sapiens (human)
receptor complexShort transient receptor potential channel 1Homo sapiens (human)
cation channel complexShort transient receptor potential channel 1Homo sapiens (human)
plasma membraneShort transient receptor potential channel 1Homo sapiens (human)
plasma membraneShort transient receptor potential channel 3Homo sapiens (human)
cation channel complexShort transient receptor potential channel 3Homo sapiens (human)
plasma membraneShort transient receptor potential channel 3Homo sapiens (human)
endoplasmic reticulumStromal interaction molecule 1Homo sapiens (human)
endoplasmic reticulum membraneStromal interaction molecule 1Homo sapiens (human)
microtubuleStromal interaction molecule 1Homo sapiens (human)
plasma membraneStromal interaction molecule 1Homo sapiens (human)
cortical endoplasmic reticulumStromal interaction molecule 1Homo sapiens (human)
sarcoplasmic reticulum membraneStromal interaction molecule 1Homo sapiens (human)
plasma membrane raftStromal interaction molecule 1Homo sapiens (human)
endoplasmic reticulumStromal interaction molecule 1Homo sapiens (human)
plasma membraneStromal interaction molecule 1Homo sapiens (human)
fibrillar centerInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
cytosolInositol hexakisphosphate kinase 1Homo sapiens (human)
nucleusInositol hexakisphosphate kinase 1Homo sapiens (human)
cytoplasmInositol hexakisphosphate kinase 1Homo sapiens (human)
plasma membraneCalcium release-activated calcium channel protein 1Homo sapiens (human)
membraneCalcium release-activated calcium channel protein 1Homo sapiens (human)
basolateral plasma membraneCalcium release-activated calcium channel protein 1Homo sapiens (human)
plasma membrane raftCalcium release-activated calcium channel protein 1Homo sapiens (human)
membrane raftCalcium release-activated calcium channel protein 1Homo sapiens (human)
calcium channel complexCalcium release-activated calcium channel protein 1Homo sapiens (human)
membraneCalcium release-activated calcium channel protein 1Homo sapiens (human)
endoplasmic reticulumStromal interaction molecule 2Homo sapiens (human)
endoplasmic reticulum membraneStromal interaction molecule 2Homo sapiens (human)
plasma membraneStromal interaction molecule 2Homo sapiens (human)
endoplasmic reticulumStromal interaction molecule 2Homo sapiens (human)
plasma membraneStromal interaction molecule 2Homo sapiens (human)
plasma membraneShort transient receptor potential channel 3 Mus musculus (house mouse)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (41)

Assay IDTitleYearJournalArticle
AID1363561Antagonist activity at TRPV1 in C57/BL6 mouse cerebellar granule cells assessed as inhibition of KCl-induced voltage dependent calcium entry at 10 uM by fura-2-based assay2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1363557Inhibition of STIM1/STIM2/Orai1 (unknown origin) expressed in mouse BV2 cells assessed as reduction of store-operated calcium entry at 100 uM preincubated for 30 mins followed by tBhQ, mediated Ca2+ depletion and re-addition measured for 600 secs by Fluo-2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1578742Inhibition of ORAI (unknown origin) assessed as reduction in Ang2-induced NFAT translocation2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.
AID1363551Modulation of STIM1/STIM2/Orai1 in mouse BV2 cells assessed as induction of store-operated calcium entry by measuring residual activity at 10 uM preincubated for 30 mins followed by tBhQ-mediated Ca2+ depletion and Ca2+ re-addition to extracellular soluti2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1363563Antagonist activity at TRPV1 (unknown origin) expressed in HEK cells assessed as inhibition of capsaicin-induced calcium increase at 10 uM by fura-2-based assay2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1363564Antagonist activity at TRPM8 (unknown origin) expressed in HEK cells assessed as inhibition of menthol -mediated calcium increase at 10 uM by fura-2-based assay2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1363592Induction of store-operated calcium entry in human Jurkat cells assessed as induction of store-operated calcium entry by measuring residual activity at 100 uM preincubated for 30 mins followed by tBhQ-mediated Ca2+ depletion and Ca2+ re-addition to extrac2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1709646Neuroprotective activity in Sprague-Dawley rat primary hippocampal neurons assessed as reduction in Abeta-induced dendrites damage at 0.25 to 1 uM incubated for 16 hrs by MAP2 staining based assay2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.
AID1709642Metabolic stability in mouse liver microsomes assessed as half life at 10 mM measured up to 240 mins in presence of NADPH regeneration system by LC-MS analysis2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.
AID1709631Inhibition of human TRPC3 expressed in HEK293 cells assessed as inhibition of GSK170-induced current in presence of 2 mM extracellular calcium by whole cell patch-clamp method2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.
AID1363591Modulation of TRPC1/TRPC3/STIM1/Orai1 in HEK cells assessed as induction of store-operated calcium entry by measuring residual activity at 100 uM preincubated for 30 mins followed by tBhQ-mediated Ca2+ depletion and Ca2+ re-addition to extracellular solut2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1363552Modulation of TRPC1/TRPC3/STIM1/Orai1 in HEK cells assessed as induction of store-operated calcium entry by measuring residual activity at 10 uM preincubated for 30 mins followed by tBhQ-mediated Ca2+ depletion and Ca2+ re-addition to extracellular soluti2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1363555Modulation of TRPC1/TRPC3/STIM1/Orai1 in HEK cells assessed as induction of store-operated calcium entry by measuring residual activity preincubated for 30 mins followed by tBhQ-mediated Ca2+ depletion and Ca2+ re-addition to extracellular solution measur2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1363556Induction of store-operated calcium entry in human Jurkat cells assessed as induction of store-operated calcium entry by measuring residual activity preincubated for 30 mins followed by tBhQ-mediated Ca2+ depletion and Ca2+ re-addition to extracellular so2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1709574Cytotoxicity against HEK cells assessed as cell viability at 10 uM measured after 24 hrs by MTT assay relative to control2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry.
AID1709632Inhibition of human TRPC3 expressed in HEK293 cells assessed as inhibition of OAG-induced current at 0.001 to 10 uM by whole cell patch-clamp method2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.
AID1363553Induction of store-operated calcium entry in human Jurkat cells assessed as induction of store-operated calcium entry by measuring residual activity at 10 uM preincubated for 30 mins followed by tBhQ-mediated Ca2+ depletion and Ca2+ re-addition to extrace2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1363565Metabolic stability in CD1 mouse plasma assessed as residual compound level at 50 uM after 30 mins by LC-UV analysis2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1363558Cytotoxicity against HEK cells assessed as cell viability at 10 uM by MTT assay relative to control2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1578741Inhibition of TRPC3 (unknown origin)2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.
AID1363562Antagonist activity at TRPM8 in C57/BL6 mouse cerebellar granule cells assessed as inhibition of KCl-induced voltage dependent calcium entry at 10 uM by fura-2-based assay2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1709639Inhibition of STIM/Orai1 (unknown origin) expressed in HEK293 cells assessed as reduction in thapsigargin-induced Ca2+ influx at 10 uM in presence of Ca2+ by whole cell patch clamp method2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.
AID1709575Inhibition of SOCE channel in tBhQ-treated HEK cells assessed as reduction in calcium entry preincubated for 600 secs followed by calcium addition by Fura-2 AM by fluorescence microscopic analysis2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry.
AID1709645Toxicity in NSG/ICR mouse assessed as body weight loss at 200 mg/kg, ip administered once daily for 5 days2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.
AID1709643Metabolic stability in rat liver microsomes assessed as half life at 10 mM measured up to 240 mins in presence of NADPH regeneration system by LC-MS analysis2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.
AID1709647Inhibition of mouse TRPC3 expressed in HEK293 cells assessed as inhibition of Ca2+ influx by whole cell patch-clamp method2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.
AID1578743Inhibition of YFP-tagged TRPC3 (unknown origin) expressed in HEK293 cells assessed as reduction carbhocol-induced receptor operated Calcium influx after 5 mins by fura-2-AM dye based assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.
AID1578744Inhibition of ORAI/STIM1 in thapsigargin treated rat RBL2H3 cells assessed as reduction in store-operated calcium entry after 5 mins by fura-2-AM dye based assay2019Journal of medicinal chemistry, 09-12, Volume: 62, Issue:17
Review of Transient Receptor Potential Canonical (TRPC5) Channel Modulators and Diseases.
AID1709630Inhibition of human TRPC3 expressed in HEK293 cells assessed as inhibition of GSK170-induced current in absence of extracellular calcium by whole cell patch-clamp method2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.
AID1709641Metabolic stability in human liver microsomes assessed as half life at 10 mM measured up to 240 mins in presence of NADPH regeneration system by LC-MS analysis2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.
AID1363590Modulation of STIM1/STIM2/Orai1 in mouse BV2 cells assessed as induction of store-operated calcium entry by measuring residual activity at 100 uM preincubated for 30 mins followed by tBhQ-mediated Ca2+ depletion and Ca2+ re-addition to extracellular solut2018Journal of medicinal chemistry, 11-08, Volume: 61, Issue:21
Pyrtriazoles, a Novel Class of Store-Operated Calcium Entry Modulators: Discovery, Biological Profiling, and in Vivo Proof-of-Concept Efficacy in Acute Pancreatitis.
AID1709577Stability in CD-1 mouse liver S9 fraction assessed as parent compound remaining at 50 uM measured after 60 mins by HPLC-UV analysis2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry.
AID1709629Inhibition of human TRPC3 expressed in HEK293 cells assessed as inhibition of GSK170-induced current at 10 uM in absence of extracellular calcium by whole cell patch-clamp method relative to control2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.
AID1709648Toxicity in NSG/ICR mouse assessed as survival at 200 mg/kg, ip administered once daily for 5 days2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
Discovery of a Highly Selective and Potent TRPC3 Inhibitor with High Metabolic Stability and Low Toxicity.
AID1709573Inhibition of SOCE channel in tBhQ-treated HEK cells assessed as reduction in calcium entry by measuring residual activity at 10 uM preincubated for 600 secs followed by calcium addition by Fura-2 AM by fluorescence microscopic analysis relative to contro2021ACS medicinal chemistry letters, Apr-08, Volume: 12, Issue:4
1,2,4-Oxadiazole-Bearing Pyrazoles as Metabolically Stable Modulators of Store-Operated Calcium Entry.
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1347160Primary screen NINDS Rhodamine qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1347159Primary screen GU Rhodamine qHTS for Zika virus inhibitors: Unlinked NS2B-NS3 protease assay2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346581Human TRPC3 (Transient Receptor Potential channels)2009Proceedings of the National Academy of Sciences of the United States of America, Mar-31, Volume: 106, Issue:13
Selective and direct inhibition of TRPC3 channels underlies biological activities of a pyrazole compound.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (22.22)29.6817
2010's3 (33.33)24.3611
2020's4 (44.44)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.62 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.92 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (11.11%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (88.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]